Effectiveness and Safety of Ruxolitinib Cream 15 mg/g in Patients With Non‐Segmental Vitiligo: A Real‐Life Study
International Journal of Dermatology · 2026-04 · 65 (4) · 816-818
DOI: 10.1111/ijd.70049 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 01.09.2025. Verfasst von Mattia Cristallo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area, Regional Reference Center for Allergic and Immunological Diseases, University of B…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Eustachio Nettis has a conflict of interest with Sanofi, Abbvie, Leo Pharma, Almirall, Gsk, and Astra-Zeneca. The remaining authors have no conflicts of interest that are directly relevant to the content of this article. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area, Regional Reference Center for Allergic and Immunological Diseases, University of Bari Aldo Moro, Bari, Italy.
- Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
ORCID-Profile: Mattia Cristallo, Michelina Francesca Daddato, Marco Casciaro, Sebastiano Gangemi
Zitieren
APA
Cristallo, M., Zaza, I., Daddato, M. F., Muolo, L., Pugliese, F., D'Amico, A., Casciaro, M., Gangemi, S., & Nettis, E. (2026). Effectiveness and Safety of Ruxolitinib Cream 15 mg/g in Patients With Non‐Segmental Vitiligo: A Real‐Life Study. International Journal of Dermatology, 65(4), 816-818. https://doi.org/10.1111/ijd.70049
Vancouver
Cristallo M, Zaza I, Daddato MF, Muolo L, Pugliese F, D'Amico A, et al. Effectiveness and Safety of Ruxolitinib Cream 15 mg/g in Patients With Non‐Segmental Vitiligo: A Real‐Life Study. International Journal of Dermatology. 2026;65(4):816-818. doi:10.1111/ijd.70049
BibTeX
@article{Cristallo2026,
author = {Cristallo, Mattia and Zaza, Ippolita and Daddato, Michelina Francesca and Muolo, Loredana and Pugliese, Francesco and D'Amico, Alice and Casciaro, Marco and Gangemi, Sebastiano and Nettis, Eustachio},
title = {Effectiveness and Safety of Ruxolitinib Cream 15 mg/g in Patients With Non‐Segmental Vitiligo: A Real‐Life Study},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {4},
pages = {816--818},
doi = {10.1111/ijd.70049}
}
EUVIMED